Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Change in Accured Expenses: 2023-2025

Historic Change in Accured Expenses for Upstream Bio (UPB) over the last 2 years, with Sep 2025 value amounting to -$481,000.

  • Upstream Bio's Change in Accured Expenses fell 285.71% to -$481,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.9 million, marking a year-over-year increase of 644.44%. This contributed to the annual value of $1.5 million for FY2024, which is 258.29% up from last year.
  • As of Q3 2025, Upstream Bio's Change in Accured Expenses stood at -$481,000, which was down 113.65% from $3.5 million recorded in Q2 2025.
  • In the past 5 years, Upstream Bio's Change in Accured Expenses registered a high of $3.5 million during Q2 2025, and its lowest value of -$1.9 million during Q1 2025.
  • Over the past 3 years, Upstream Bio's median Change in Accured Expenses value was $320,500 (recorded in 2024), while the average stood at $418,000.
  • Within the past 5 years, the most significant YoY rise in Upstream Bio's Change in Accured Expenses was 822.77% (2025), while the steepest drop was 285.71% (2025).
  • Upstream Bio's Change in Accured Expenses (Quarterly) stood at $639,000 in 2023, then surged by 174.65% to $1.8 million in 2024, then plummeted by 285.71% to -$481,000 in 2025.
  • Its last three reported values are -$481,000 in Q3 2025, $3.5 million for Q2 2025, and -$1.9 million during Q1 2025.